Outset Medical, Inc.
HealthcareNASDAQ:OM · NASDAQ Global Select
+$0.19 today
Vol 0.13M · Avg 0.16M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-64.3%
avg -98.1%
ROIC
-29.2%
avg -48.1%
ROA
-30.9%
avg -42.7%
Analysis
ROIC is currently the strongest return metric at -29.2% versus its period average of -48.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Leslie L. Trigg | President, Chief Executive Officer & Chairman | $1.06M | — | 55 | $98,874.00 | 0.53% |
John L. Brottem | General Counsel & Secretary | $566,087.00 | — | 52 | $30,277.00 | 0.16% |
Marc Nash | Executive Vice President of R&D, Operations & Service | $524,128.00 | — | 37 | $38,393.00 | 0.21% |
Renee Gaeta | Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer | $336,048.00 | — | 45 | $113,753.00 | 0.61% |
Michael Aragon | Chief Medical Officer | — | — | — | $2.52M | 13.59% |
Brett Fogg | Senior Vice President of R&D & Operations | — | — | — | — | — |
Derick Elliott | Executive Vice President of Commercial | — | — | — | $96,000.00 | 0.52% |
John Geraci | Vice President & Controller | — | — | — | $30,277.00 | 0.16% |
James S. Mazzola | Vice President of Corporate Communications & Investor Relations | — | — | — | $80,349.00 | 0.43% |
Brittni McGill | Chief Nursing Officer | — | — | — | — | — |
Amelia Merrill | Vice President of People Operations & Culture | — | — | — | — | — |
Dinamarie Stefani | Senior Vice President of Regulatory Affairs & Quality Assurance | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
23
$342,306.39
Net Sentiment
$342,306.39
Net selling
Most Active
Trigg Leslie
7 transactions
1–10 of 23
Analysis
Insiders reported 0 buys worth $0.00 and 23 sells worth $342,306.39 over the last 12 months. That adds up to net selling of $342,306.39. Trigg Leslie was the most active insider with 7 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +97.1% | +7.0% (8yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +97.1% over three years. Forward estimates point to Revenue at +7.0% (8yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Viemed Healthcare, Inc.
NASDAQ:VMD
$400.62M
Shoulder Innovations, Inc.
NYSE:SI
$387.80M
Perspective Therapeutics, Inc.
AMEX:CATX
$227.89M
Owens & Minor, Inc.
OMI
$207.07M
Inogen, Inc.
NASDAQ:INGN
$173.28M
Quanterix Corporation
NASDAQ:QTRX
$146.03M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$128.21M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$118.59M
Solana Company
NASDAQ:HSDT
$89.92M
Who manages OM?
Outset Medical, Inc. (OM) lists 12 active executives. The top listed executive is Renee Gaeta, Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer.
Are OM insiders buying or selling?
Recent insider activity shows net buying of $650,117.73.
Explore More
Continue the stock analysis
Jump to another research area for this company.